CNS & Neurological Disorders - Drug Targets,
Journal Year:
2009,
Volume and Issue:
8(6), P. 403 - 421
Published: Dec. 1, 2009
The
therapeutic
potential
of
cannabinoids
has
been
the
topic
extensive
investigation
following
discovery
cannabinoid
receptors
and
their
endogenous
ligands.
Cannabinoid
ligands
are
present
at
supraspinal,
spinal
peripheral
levels.
Cannabinoids
suppress
behavioral
responses
to
noxious
stimulation
nociceptive
processing
through
activation
CB1
CB2
receptor
subtypes.
Endocannabinoids,
brains
own
cannabis-like
substances,
share
same
molecular
target
as
Δ9-tetrahydrocannabinol,
main
psychoactive
component
in
cannabis.
Endocannabinoids
serve
synaptic
circuit
breakers
regulate
multiple
physiological
pathological
conditions,
e.g.
regulation
food
intake,
immunomodulation,
inflammation,
analgesia,
cancer,
addictive
behavior,
epilepsy
others.
This
review
will
focus
on
uncovering
roles
anandamide
2-arachidonoylglycerol,
two
best
characterized
endocannabinoids
identified
date,
controlling
responding.
released
under
modulating
responding
different
levels
neuraxis
be
emphasized
this
review.
Effects
modulation
endocannabinoid
inhibition
hydrolysis
uptake
is
also
compared
with
effects
exogenous
administration
synthetic
acute,
inflammatory
neuropathic
pain
models.
Finally,
signaling
system
discussed
context
identifying
novel
pharmacotherapies
for
treatment
pain.
Keywords:
Anandamide,
2-arachidonoyl
glycerol,
fatty
acid
amide
hydrolase,
monoacylglycerol
lipase,
transporter,
inflammatory,
International Journal of Molecular Sciences,
Journal Year:
2018,
Volume and Issue:
19(8), P. 2164 - 2164
Published: July 24, 2018
Pain
has
been
considered
as
a
concept
of
sensation
that
we
feel
reaction
to
the
stimulus
our
surrounding,
putting
us
in
harm’s
way
and
acting
form
defense
mechanism
body
permanently
installed
into
its
system.
However,
pain
leads
huge
chunk
finances
within
healthcare
system
with
continuous
rehabilitation
patients
adverse
sensations,
which
might
reduce
not
only
their
quality
life
but
also
productivity
at
work
setting
back
pace
economy.
It
may
look
like
deal
factor
an
issue
for
majority
us,
it
becomes
economical
burden.
Although
researched
understood
by
numerous
researches,
from
definition,
action
inhibition
hopes
finding
absolute
solution
victims
pain,
pathways
sensation,
neurotransmitters
involved
producing
such
are
comprehensively
reviewed.
Therefore,
this
review
article
aims
put
place
thorough
understanding
major
conditions
experience—nociceptive,
inflammatory
physiologically
dysfunction,
neuropathic
modulation
feedback
systems.
Moreover,
complete
conduction
is
compiled
article,
elucidating
understandings
various
researches
breakthroughs.
Chemistry & Biodiversity,
Journal Year:
2007,
Volume and Issue:
4(8), P. 1614 - 1648
Published: Aug. 1, 2007
Abstract
Cannabis
sativa
L.
is
possibly
one
of
the
oldest
plants
cultivated
by
man,
but
has
remained
a
source
controversy
throughout
its
history.
Whether
pariah
or
panacea,
this
most
versatile
botanical
provided
mirror
to
medicine
and
pointed
way
in
last
two
decades
toward
host
medical
challenges
from
analgesia
weight
loss
through
discovery
myriad
biochemical
attributes
endocannabinoid
system
wherein
many
components
operate.
This
study
surveys
history
cannabis,
genetics
preparations.
A
review
cannabis
usage
Ancient
Egypt
will
serve
as
an
archetype,
while
examining
first
mentions
various
Old
World
cultures
their
pertinence
for
contemporary
scientific
investigation.
historians
past
have
promising
clues
potential
treatments
wide
array
currently
puzzling
syndromes
including
chronic
pain,
spasticity,
cancer,
seizure
disorders,
nausea,
anorexia,
infectious
disease
that
remain
21st
century
medicine.
Information
gleaned
administration
forms
may
provide
useful
points
departure
research
into
novel
delivery
techniques
standardization
cannabis‐based
medicines
allow
prescription
treatment
these
intractable
conditions.
Glia,
Journal Year:
2010,
Volume and Issue:
58(9), P. 1017 - 1030
Published: March 29, 2010
CB1
and
CB2
receptors
are
activated
by
a
plethora
of
cannabinoid
compounds,
be
they
endogenously-produced,
plant-derived
or
synthetic.
These
expressed
microglia,
astrocytes
astrocytomas,
their
activation
regulates
these
cells'
differentiation,
functions
viability.
Recent
studies
show
that
glial
cells
also
express
cannabinoid-like
receptors,
different
cell
functions,
but
control
This
review
summarizes
this
evidence,
discusses
how
selective
compounds
targeting
constitute
promising
therapeutics
to
manage
neuroinflammation
eradicate
malignant
astrocytomas.
Importantly,
the
should
provide
therapeutic
relieve
without
inducing
typical
psychotropic
effects
possible
addictive
properties
associated
with
use
Delta9-tetrahydrocannabinol,
main
ingredient
produced
plant
Cannabis
sativa.
CNS & Neurological Disorders - Drug Targets,
Journal Year:
2009,
Volume and Issue:
8(6), P. 403 - 421
Published: Dec. 1, 2009
The
therapeutic
potential
of
cannabinoids
has
been
the
topic
extensive
investigation
following
discovery
cannabinoid
receptors
and
their
endogenous
ligands.
Cannabinoid
ligands
are
present
at
supraspinal,
spinal
peripheral
levels.
Cannabinoids
suppress
behavioral
responses
to
noxious
stimulation
nociceptive
processing
through
activation
CB1
CB2
receptor
subtypes.
Endocannabinoids,
brains
own
cannabis-like
substances,
share
same
molecular
target
as
Δ9-tetrahydrocannabinol,
main
psychoactive
component
in
cannabis.
Endocannabinoids
serve
synaptic
circuit
breakers
regulate
multiple
physiological
pathological
conditions,
e.g.
regulation
food
intake,
immunomodulation,
inflammation,
analgesia,
cancer,
addictive
behavior,
epilepsy
others.
This
review
will
focus
on
uncovering
roles
anandamide
2-arachidonoylglycerol,
two
best
characterized
endocannabinoids
identified
date,
controlling
responding.
released
under
modulating
responding
different
levels
neuraxis
be
emphasized
this
review.
Effects
modulation
endocannabinoid
inhibition
hydrolysis
uptake
is
also
compared
with
effects
exogenous
administration
synthetic
acute,
inflammatory
neuropathic
pain
models.
Finally,
signaling
system
discussed
context
identifying
novel
pharmacotherapies
for
treatment
pain.
Keywords:
Anandamide,
2-arachidonoyl
glycerol,
fatty
acid
amide
hydrolase,
monoacylglycerol
lipase,
transporter,
inflammatory,